In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
Aspire Biopharma Holdings Inc (NASDAQ: ASBP) closed the day trading at $0.51 up 16.17% from the previous closing price of $0.44. In other words, the price has increased by $16.17 from its previous closing price. On the day, 0.72 million shares were traded. ASBP stock price reached its highest trading level at $0.5559 during the session, while it also had its lowest trading level at $0.42.
Ratios:
For a better understanding of ASBP, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.01 and its Current Ratio is at 0.01. In the meantime, Its Debt-to-Equity ratio is 59.33 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASBP now has a Market Capitalization of 23463824 and an Enterprise Value of 200834672.
Stock Price History:
The Beta on a monthly basis for ASBP is 1.00, which has changed by -0.95413667 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, ASBP has reached a high of $15.80, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is -87.93%, while the 200-Day Moving Average is calculated to be -94.65%.
Shares Statistics:
Over the past 3-months, ASBP traded about 520.99K shares per day on average, while over the past 10 days, ASBP traded about 228880 shares per day. A total of 48.90M shares are outstanding, with a floating share count of 36.54M. Insiders hold about 25.27% of the company’s shares, while institutions hold 0.95% stake in the company.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
